Drug Solutions Podcast: Alternative delivery methods for biologics: Where are we?

The biopharmaceutical industry has long been working on methods to deliver biologic therapeutics in a way that improves ease of use and patient compliance. Biologics are now largely administered parenterally, a method that can be painful and undesirable for patients. In addition, parenteral formulations of biologics require a tightly temperature-controlled environment. Researchers have long been exploring means of formulating biologic molecules that can ensure their molecular stability and mitigate some of the stringent manufacturing requirements. In this episode of the Drug Solutions podcast, Feliza Mirasol, Science Editor at Pharmaceutical Technology®, Pharmaceutical Technology EuropeTM and BioPharm International® examines the challenges of formulating biologic drugs and progress to date in developing alternative delivery routes for biologic drugs, together with Nigel Theobald, CEO of N4 Pharma, a specialty pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines.

About the speaker

Nigel Theobald, CEO, N4 Pharma

Nigel Theobald is CEO of N4 Pharma, a specialty pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines. Theobald has over 25 years' experience in healthcare, business building, strategy development and implementation, and a strong network covering all aspects of pharmaceutical product development and commercialization. He was Head of Healthcare Brands at Boots Group plc in 2002 before leaving to build a number of successful businesses, including Oxford Pharmascience Group plc, which he built within five years into an AIM-listed company with a market capitalization of £40 million (US$53 million) on his departure. Theobald founded N4 Pharma in 2014.

About the Drug Solutions Podcast

Pharmaceutical Technology presents the Drug Solutions podcast, where editors speak with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join experts as they provide insight into your most important questions – from technologies to strategies to regulations related to drug development and manufacturing.

Listen to this podcast on SoundCloud, Spotify, Google Podcasts or Apple Podcasts.